Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up

Mismatch repair cancer syndrome 3

MONDO:0030841

An autosomal recessive constitutional mismatch repair deficiency syndrome caused by pathogenic variants in the MSH6 mismatch repair gene is characterized by a high risk of childhood cancers, including hematological malignancies, brain tumors, and colorectal

Also known as: MMRCS3, MSH6-related constitutional mismatch repair deficiency syndrome, mismatch repair cancer syndrome 3

3 clinical trials for this condition and its sub-types.

Follow this condition — get notified about new trials

Broader categories

Disease (680) Metabolic disease (233) Hereditary disease (176) Inborn errors of metabolism (45) Human disease (14) DNA repair disease (13) Mismatch repair cancer syndrome (5) Autosomal recessive disease (4) Disease of genetic or genomic mechanism (2) Autosomal genetic disease (0)
Trials to join now! 1 Not yet finished but already full! 1 Completed 1
Sort by
  • New drug combo targets Hard-to-Treat cancers in early trial

    Disease control Recruiting now

    This study tests a new drug called AZD4956, alone or with other cancer drugs, in people with advanced or spreading solid tumors that have a specific DNA repair defect (HRR deficiency). The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. …

    Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control

    Last updated Aug 13, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space